These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 23043158)

  • 21. Fenofibrate for Diabetic Retinopathy.
    Stewart S; Lois N
    Asia Pac J Ophthalmol (Phila); 2018; 7(6):422-426. PubMed ID: 30058790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
    Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
    Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of cGAS-STING signaling by PPARα in a mouse model of ischemia-induced retinopathy.
    Ma X; Wu W; Liang W; Takahashi Y; Cai J; Ma JX
    Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2208934119. PubMed ID: 36409895
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The peroxisome proliferator-activated receptor pan-agonist bezafibrate suppresses microvascular inflammatory responses of retinal endothelial cells and vascular endothelial growth factor production in retinal pigmented epithelial cells.
    Usui-Ouchi A; Ouchi Y; Ebihara N
    Int Immunopharmacol; 2017 Nov; 52():70-76. PubMed ID: 28866026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Modified Low-Density Lipoproteins and Fenofibrate on an Outer Blood-Retina Barrier Model: Implications for Diabetic Retinopathy.
    Fu D; Yu JY; Connell AR; Hookham MB; McLeese RH; Lyons TJ
    J Ocul Pharmacol Ther; 2020 Dec; 36(10):754-764. PubMed ID: 33107777
    [No Abstract]   [Full Text] [Related]  

  • 26. Ischaemia-induced retinal neovascularisation and diabetic retinopathy in mice with conditional knockout of hypoxia-inducible factor-1 in retinal Müller cells.
    Lin M; Chen Y; Jin J; Hu Y; Zhou KK; Zhu M; Le YZ; Ge J; Johnson RS; Ma JX
    Diabetologia; 2011 Jun; 54(6):1554-66. PubMed ID: 21360191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PPARα Agonist Stimulated Angiogenesis by Improving Endothelial Precursor Cell Function Via a NLRP3 Inflammasome Pathway.
    Deng Y; Han X; Yao Z; Sun Y; Yu J; Cai J; Ren G; Jiang G; Han F
    Cell Physiol Biochem; 2017; 42(6):2255-2266. PubMed ID: 28817808
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.
    Blednov YA; Black M; Benavidez JM; Stamatakis EE; Harris RA
    Alcohol Clin Exp Res; 2016 Mar; 40(3):553-62. PubMed ID: 26857685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-409-5p promotes retinal neovascularization in diabetic retinopathy.
    Wang Y; Lin W; Ju J
    Cell Cycle; 2020 Jun; 19(11):1314-1325. PubMed ID: 32292119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization.
    Huang L; Liang W; Zhou K; Wassel RA; Ridge ZD; Ma JX; Wang B
    Biology (Basel); 2021 Dec; 10(12):. PubMed ID: 34943243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PPARalpha agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition.
    Panigrahy D; Kaipainen A; Huang S; Butterfield CE; Barnés CM; Fannon M; Laforme AM; Chaponis DM; Folkman J; Kieran MW
    Proc Natl Acad Sci U S A; 2008 Jan; 105(3):985-90. PubMed ID: 18199835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARalpha agonist fenofibrate improves diabetic nephropathy in db/db mice.
    Park CW; Zhang Y; Zhang X; Wu J; Chen L; Cha DR; Su D; Hwang MT; Fan X; Davis L; Striker G; Zheng F; Breyer M; Guan Y
    Kidney Int; 2006 May; 69(9):1511-7. PubMed ID: 16672921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pemafibrate Prevents Retinal Pathological Neovascularization by Increasing FGF21 Level in a Murine Oxygen-Induced Retinopathy Model.
    Tomita Y; Ozawa N; Miwa Y; Ishida A; Ohta M; Tsubota K; Kurihara T
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
    Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
    Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PPAR
    Mandala A; Chen WJ; Armstrong A; Malhotra MR; Chavalmane S; McCommis KS; Chen A; Carpenter D; Biswas P; Gnana-Prakasam JP
    Am J Physiol Gastrointest Liver Physiol; 2021 Sep; 321(4):G262-G269. PubMed ID: 34287090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression.
    Enright JM; Zhang S; Thebeau C; Siebert E; Jin A; Gadiraju V; Zhang X; Chen S; Semenkovich CF; Rajagopal R
    J Clin Med; 2020 Dec; 10(1):. PubMed ID: 33396512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenic Role of PPARα Downregulation in Corneal Nerve Degeneration and Impaired Corneal Sensitivity in Diabetes.
    Matlock HG; Qiu F; Malechka V; Zhou K; Cheng R; Benyajati S; Whelchel A; Karamichos D; Ma JX
    Diabetes; 2020 Jun; 69(6):1279-1291. PubMed ID: 32213513
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways.
    Cai Y; Tu H; Wu C; Liu T; Chen S; Shen L; Xiao Q; Zhao S; Xu S; Lin W; Yan P; Dong J
    J Ethnopharmacol; 2024 Jan; 318(Pt A):116843. PubMed ID: 37414197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated diabetic nephropathy in mice lacking the peroxisome proliferator-activated receptor alpha.
    Park CW; Kim HW; Ko SH; Chung HW; Lim SW; Yang CW; Chang YS; Sugawara A; Guan Y; Breyer MD
    Diabetes; 2006 Apr; 55(4):885-93. PubMed ID: 16567507
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fenofibrate Inhibits Cytochrome P450 Epoxygenase 2C Activity to Suppress Pathological Ocular Angiogenesis.
    Gong Y; Shao Z; Fu Z; Edin ML; Sun Y; Liegl RG; Wang Z; Liu CH; Burnim SB; Meng SS; Lih FB; SanGiovanni JP; Zeldin DC; Hellström A; Smith LEH
    EBioMedicine; 2016 Nov; 13():201-211. PubMed ID: 27720395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.